🧠S1P & LPA receptors: promising targets for neuroprotection. Fingolimod (FTY720) protects across multiple CNS disorders; LPA1 antagonists show benefits in TBI, stroke & spinal cord injury.
🔗 https://t.co/e6xT6SerwT
#Neurodegeneration#CNSResearch#Neuroprotection#S1P#LPA
🌍 Connecting the global #neuroscience research community
ENT provides an open platform for sharing research and clinical insights in #neurodegeneration, #neuroprotection, and #neurorestoration.
🆓Submit your research and join the global discussion. No APC before July 31, 2026.
🧠 Beyond the gut: how your mouth, skin, and nose microbiomes might influence neurodegeneration.
This review highlights mechanisms & potential microbiome-based therapies.
📖 https://t.co/nHJ9yO5HuY
#Microbiome#GutBrainAxis#Alzheimers#Parkinsons#Neurodegeneration
🌟 ENT Spotlight: Non-motor symptoms in #ParkinsonsDisease—cognition, sleep, smell, GI—can appear years before motor deficits. A review updates their pathophysiology & impact on patient disability.
🔗 https://t.co/OCSUPFICsf
#Neurodegeneration#NonMotorSymptoms#ENTJournal
🌍 Calling all #neuroscience researchers!
Our special issue "Breakthroughs in Mechanisms and Treatments for #NeurodegenerativeDiseases" is open for submissions. Share your latest insights before Dec 31, 2026, and join this global conversation!
#FreePublication NOW! #Alzheimers
⚡ #tVNS – stimulating the vagus nerve through the ear or neck – is emerging as an anti‑inflammatory adjuvant for cancer and heart failure.
But parameters vary widely. Standardization needed.
📖 https://t.co/RrUN80qq0n
#VagusNerve#Neuroimmunology#HeartFailure#Cancer